|
TBP expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.566600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.302400E-01 |
| Normal-vs-Stage2 |
5.328200E-01 |
| Normal-vs-Stage3 |
7.770500E-02 |
| Normal-vs-Stage4 |
5.237800E-02 |
| Stage1-vs-Stage2 |
2.630600E-01 |
| Stage1-vs-Stage3 |
1.436460E-02 |
| Stage1-vs-Stage4 |
1.351670E-02 |
| Stage2-vs-Stage3 |
5.917600E-01 |
| Stage2-vs-Stage4 |
4.559800E-01 |
| Stage3-vs-Stage4 |
7.439800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.795960E-01 |
| Normal-vs-AfricanAmerican |
1.398230E-01 |
| Normal-vs-Asian |
2.808800E-01 |
| Caucasian-vs-AfricanAmerican |
7.383200E-03 |
| Caucasian-vs-Asian |
9.184300E-02 |
| AfricanAmerican-vs-Asian |
6.295600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.497850E-01 |
| Normal-vs-Female |
5.207200E-01 |
| Male-vs-Female |
2.398000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.171400E-01 |
| Normal-vs-Age(41-60Yrs) |
8.198600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.635790E-01 |
| Normal-vs-Age(81-100Yrs) |
4.242400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.965200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.126200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.287600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.187600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.050400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.365200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.70288999999935E-05 |
| Normal-vs-Grade 2 |
1.428230E-01 |
| Normal-vs-Grade 3 |
1.597850E-02 |
| Normal-vs-Grade 4 |
8.244200E-04 |
| Grade 1-vs-Grade 2 |
9.261900E-03 |
| Grade 1-vs-Grade 3 |
3.80389999998787E-06 |
| Grade 1-vs-Grade 4 |
3.29090000028565E-07 |
| Grade 2-vs-Grade 3 |
2.34009999999785E-05 |
| Grade 2-vs-Grade 4 |
1.57422000000018E-05 |
| Grade 3-vs-Grade 4 |
1.138210E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.178820E-01 |
| Normal-vs-ccB subtype |
1.398550E-03 |
| ccA subtype-vs-ccB subtype |
2.00000000005751E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.845800E-01 |
| Normal-vs-N1 |
8.042200E-02 |
| N0-vs-N1 |
7.002100E-02 |
|
|
